Five-year follow-up of tacrolimus as primary immunosuppressant after liver transplantation

Transplant Proc. 1998 Aug;30(5):2179-81. doi: 10.1016/s0041-1345(98)00580-6.
No abstract available

Publication types

  • Clinical Trial
  • Comparative Study
  • Randomized Controlled Trial

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Azathioprine / therapeutic use
  • Cyclosporine / therapeutic use*
  • Drug Therapy, Combination
  • Follow-Up Studies
  • Graft Survival*
  • Humans
  • Immunosuppressive Agents / therapeutic use*
  • Liver Transplantation / immunology*
  • Liver Transplantation / mortality
  • Methylprednisolone / therapeutic use
  • Middle Aged
  • Neoplasms / epidemiology
  • Postoperative Complications / epidemiology
  • Survival Rate
  • Tacrolimus / therapeutic use*
  • Time Factors

Substances

  • Immunosuppressive Agents
  • Cyclosporine
  • Azathioprine
  • Tacrolimus
  • Methylprednisolone